Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Denali Therapeutics stock

Learn how to easily invest in Denali Therapeutics stock.

Denali Therapeutics Inc is a biotechnology business based in the US. Denali Therapeutics shares (DNLI) are listed on the NASDAQ and all prices are listed in US Dollars. Denali Therapeutics employs 395 staff and has a trailing 12-month revenue of around $112.4 million.

How to buy shares in Denali Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DNLI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Denali Therapeutics stock price (NASDAQ: DNLI)

Use our graph to track the performance of DNLI stocks over time.

Denali Therapeutics shares at a glance

Information last updated 2022-09-19.
Latest market close$27.19
52-week range$20.24 - $56.08
50-day moving average $33.29
200-day moving average $32.70
Wall St. target price$68.75
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.34

Buy Denali Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Denali Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Denali Therapeutics price performance over time

Historical closes compared with the close of $27.19 from 2022-09-23

1 week (2022-09-19) -9.37%
1 month (2022-08-26) -7.33%
3 months (2022-06-24) -12.09%
6 months (2022-03-25) -18.10%
1 year (2021-09-24) -46.69%
2 years (2020-09-25) -22.62%
3 years (2019-09-26) 71.87%
5 years (2017-09-22) N/A

Denali Therapeutics financials

Revenue TTM $112.4 million
Gross profit TTM $-216,692,000
Return on assets TTM -12.96%
Return on equity TTM -29.01%
Profit margin -252.5%
Book value $7.18
Market capitalisation $3.7 billion

TTM: trailing 12 months

Denali Therapeutics share dividends

We're not expecting Denali Therapeutics to pay a dividend over the next 12 months.

Denali Therapeutics share price volatility

Over the last 12 months, Denali Therapeutics's shares have ranged in value from as little as $20.24 up to $56.08. A popular way to gauge a stock's volatility is its "beta".

DNLI.US volatility(beta: 1.7)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Denali Therapeutics's is 1.697. This would suggest that Denali Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Denali Therapeutics overview

Denali Therapeutics Inc. , a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease. The company also develops DNL310 that is in Phase I/II clinical trials for the treatment of hunter syndrome; DNL343, which is in phase 1 clinical trial the treatment of amyotrophic lateral sclerosis (ALS); AR443820/DNL788 completed a phase I clinical trial for the treatment of ALS, multiple sclerosis (MS), and Alzheimer's disease; and SAR443122/DNL758, which is in phase II clinical trial for the treatment of cutaneous lupus erythematosus. It has collaboration agreement with Takeda Pharmaceutical Company, Genentech, Inc. , Sanofi, F-star Gamma Limited, F-star Biotechnologische Forschungs-Und Entwicklungsges M. B.

Frequently asked questions

What percentage of Denali Therapeutics is owned by insiders or institutions?
Currently 16.341% of Denali Therapeutics shares are held by insiders and 77.281% by institutions.
How many people work for Denali Therapeutics?
Latest data suggests 395 work at Denali Therapeutics.
When does the fiscal year end for Denali Therapeutics?
Denali Therapeutics's fiscal year ends in December.
Where is Denali Therapeutics based?
Denali Therapeutics's address is: 161 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
What is Denali Therapeutics's ISIN number?
Denali Therapeutics's international securities identification number is: US24823R1059
What is Denali Therapeutics's CUSIP number?
Denali Therapeutics's Committee on Uniform Securities Identification Procedures number is: 24823R105

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site